SCHEMBL3523170

SCHEMBL3523170

NC(=O)Oc1ccc(CN2CCCCC/C=C/C3CC3([C]=O)NC(=O)C3CC(O)CN3C2=O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3526968 0.87 — —
SCHEMBL4166425 0.87 — —
SCHEMBL3523171 0.81 MMP1 (0.34) —
SCHEMBL16628772 0.79 ADRB3 (0.36) —
SCHEMBL16628773 0.79 ADRB3 (0.36) —
SCHEMBL995888 0.76 ALDH1A1 (0.36) —
SCHEMBL19215370 0.76 ALDH1A1 (0.36) —
SCHEMBL10156974 0.76 ALDH1A1 (0.36) —
SCHEMBL8239738 0.76 ALDH1A1 (0.36) —
SCHEMBL995885 0.76 ALDH1A1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7666834-B2 Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARMACEUTICALS LTD. (IE) 2010-02-23 — — US disclosed
US-20090105302-A1 Macrocylic Inhibitors of Hepatitis C Virus JANSSEN SCIENCES IRELAND UC (IE) 2009-04-23 — — US disclosed
Send feedback